Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | S100A4 | P26447 | 2/20 | 0.41 |
| ▸ | PTPRC | P08575 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SI | P14410 | 1/20 | 0.38 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26502971 | 0.83 | S100A4 (0.55) | TDP1ALDH1A1S100A4PTPRCHSD17B10 | |
| SCHEMBL3758839 | 0.81 | ALDH1A1 (0.57) | TDP1ALDH1A1S100A4PTPRCHSD17B10 | |
| SCHEMBL20150198 | 0.79 | HSD17B10 (0.52) | TDP1ALDH1A1HSD17B10TSHRSMN1; SMN2 | |
| SCHEMBL6870799 | 0.79 | HSD17B10 (0.52) | TDP1ALDH1A1HSD17B10TSHRSMN1; SMN2 | |
| SCHEMBL16919569 | 0.77 | AAK1 (0.43) | TDP1ALDH1A1HSD17B10TSHRMAPT | |
| SCHEMBL19974127 | 0.76 | TXNRD1 (0.46) | TDP1ALDH1A1S100A4PTPRCHSD17B10 | |
| SCHEMBL16919566 | 0.75 | KMT2A (0.44) | TDP1ALDH1A1S100A4PTPRCHSD17B10 | |
| SCHEMBL26107330 | 0.75 | ALDH1A1 (0.69) | TDP1ALDH1A1S100A4PTPRCHSD17B10 | |
| SCHEMBL10435062 | 0.75 | TSHR (0.52) | TDP1ALDH1A1S100A4PTPRCHSD17B10 | |
| SCHEMBL21155893 | 0.75 | MGAM (0.41) | TDP1ALDH1A1HSD17B10SMN1; SMN2MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11309496-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-04-19 | — | — | US | disclosed |
| US-20200335704-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-10-22 | — | — | US | disclosed |
| WO-2015108325-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2015-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11309496-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | GPX1, LEF1, OCIAD1 | TDP1 966/4885ALDH1A1 372/4885S100A4 1193/4885 |
| US-20200335704-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | GPX1, LEF1, OCIAD1 | TDP1 966/4885ALDH1A1 372/4885S100A4 1193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.